FDA Inspection
Baxalta US IncorporatedBaxalta US Incorporated – FDA Inspection, Nov 2, 2018
Record Details
This FDA Inspection record concerns Baxalta US Incorporated, with an inspection on November 2, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Abby L. Mozeke (Issuing Officer)
- Omotunde O. Osunsanmi (Issuing Officer)
View Company Profile
ID · 4005c3a2-d95d-40ae-a3b6-adc953482e8b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1072937
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Baxalta US Incorporated
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Los Angeles District Office | |
| May 31, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 13, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 20, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxalta US Incorporated
- FDA Inspection 1287588 - 2025-11-07
- FDA Inspection 1208375 - 2023-05-31
- FDA Inspection 998105 - 2016-12-13
- FDA Inspection 923173 - 2015-03-13
- FDA Inspection 801949 - 2012-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.